NASDAQ OMX

Globecomm introduces Vector, a Virtualized Video Headend for delivering hundreds of channels across multiple platforms

Dela

Highlights

  • Virtualized video headend system offers a single, compact solution that simplifies the processing, packaging and customization of video content - from acquisition and contribution to playout and distribution.
  • Scalable to hundreds of channels, Vector delivers content across DTH, OTT, IPTV, cable and terrestrial TV leveraging Globecomm's global satellite, IP and fiber network.
  • Designed with Globecomm's hallmark resiliency offering high availability.
  • Cost-effective solution that significantly reduces rack space, cabling, power and operational constraints. 

HAUPPAUGE, N.Y., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Globecomm announced today the introduction of Vector(SM), a virtualized video headend system able to support hundreds of channels and deliver content across multiple platforms.  Vector's IP-centric platform simplifies the processing, packaging and customization of video content from acquisition and contribution to playout and distribution for delivery across DTH, OTT, IPTV, cable and terrestrial TV.  It leverages Globecomm's robust satellite, IP and fiber content delivery networks and the company's extensive experience with design and integration of media infrastructure.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/10e8aecd-0762-4f80-8ecc-0568a3c46a39

Vector replaces the need for the traditional data center with a compact solution that significantly reduces rack space, cabling and power. Whether hosted on Globecomm's cloud network or implemented at a customer site, each system is designed with Globecomm's hallmark resiliency offering high availability.

"Vector marks the next step in the evolution of Globecomm's services for the media and entertainment industries, and is the culmination of many months of R&D research," said Chief Commercial Officer Bryan McGuirk.  "We've spent decades building production facilities and broadcast centers, hosting and distributing high-value media content for linear broadcast and helping customers adapt it for OTT.  The Vector virtualized video headend brings all of that capability together into one of the simplest, resilient and scalable solutions on the market."

The video headend is the technology core for video management, from ingest and storage to packaging.  In legacy headends, the workflow depends on multiple devices from different manufacturers, each performing discrete tasks and all requiring integration with sufficient redundancy to ensure reliable processing, and end-to-end communication to deliver the final content package.

Vector simplifies multiple, interdependent processes - including new compression technologies, multiple video standards and encoding advances such as adaptive bit rate - into software and data storage in an all-IP environment.  The IP environment provides a common bus to simplify process communications and ease technology upgrade management.  It provides lower and more efficient CAPEX or the replacement of capital expenditure with predictable operating expenses, and offers faster market-capturing delivery for new programs and channels, with dynamic scaling response to changes in demand.

Vector will make its debut at NAB Show New York 2017, Globecomm booth N609, being held October 18-19 at the Javits Center in New York City.

About Globecomm
Globecomm designs, integrates and operates highly sophisticated voice, video and data systems for connecting anyone to anything, anywhere.  We are differentiated by our worldwide integrated satellite, fiber, cellular and content delivery networks that offer resilient and robust connectivity over Land, Sea and Air with high availability. Technology-agnostic, Globecomm offers solutions and end-to-end managed services that best serve the needs of our customers.  Currently we support mission-critical communications and IoT capabilities for Government, Maritime, Broadcast, Enterprise, Oil & Gas and Telecom customers in over 100 countries.  

Headquartered in Hauppauge, NY, Globecomm has locations in Maryland, New Jersey, Virginia, the Netherlands, Hong Kong, South Africa, Germany, Singapore, the United Arab Emirates and Afghanistan.

www.globecomm.com

Contact Information :

Peggy Stalhut; peggy.stalhut@globecomm.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: GLOBECOMM SYSTEMS via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North24.9.2018 08:00Pressmeddelande

STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is issuing 6.8 million shares. The issue price of SEK 21 gives Asarina Pharma a pre money valuation of SEK 172 million. Conditioned that the over-allotment option of an additional 0.35 million shares is fully exercised, Asarina Pharma will be provided with a total of SEK 150.2 million before issue costs. Asarina Pharma is a Swedish biotech company focused on chronic diseases associated with the menstrual cycle. The portfolio company is developing the drug candidate sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and premenstrual migraine. A Phase IIb study is currently underway in PMDD with expected completion by the end of 2019. Furthermore, Asarina Pharma is planning a clinical Phase IIa study in menstrual migraine for the first half of 2019. Karolinska Development is a pas

Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North24.9.2018 08:00Pressmeddelande

STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is issuing 6.8 million shares. The issue price of SEK 21 gives Asarina Pharma a pre money valuation of SEK 172 million. Conditioned that the over-allotment option of an additional 0.35 million shares is fully exercised, Asarina Pharma will be provided with a total of SEK 150.2 million before issue costs. Asarina Pharma is a Swedish biotech company focused on chronic diseases associated with the menstrual cycle. The portfolio company is developing the drug candidate sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and premenstrual migraine. A Phase IIb study is currently underway in PMDD with expected completion by the end of 2019. Furthermore, Asarina Pharma is planning a clinical Phase IIa study in menstrual migraine for the first half of 2019. Karolinska Development is a pas

Immunicum AB (publ) meddelar att Pawel Kalinski och Inge Marie Svane har valts in i det vetenskapliga rådet17.9.2018 08:00Pressmeddelande

Pressmeddelande 17 september 2018 Immunicum AB (publ) meddelar att Pawel Kalinski och Inge Marie Svane har valts in i det vetenskapliga rådet Immunicum AB (publ; IMMU.ST) meddelade i dag att två ledande immun-onkologiska experter har valts in i bolagets vetenskapliga råd för att fungera som strategiska resurser för Immunicum under bolagets fortsatta kliniska utveckling av sin ledande produkt, ilixadencel. Pawel Kalinski, MD, PhD, vice ordförande för translationell forskning vid den medicinska institutionen vid Roswell Park Comprehensive Cancer Center, och Inge Marie Svane, MD, PhD, professor, chef för det kliniska cancerforskningsprogrammet på medicinska fakulteten vid Köpenhamns universitet, chef för Center för cancerimmunterapi (CCIT) samt överläkare inom onkologi, Herlevs universitetssjukhus har valts in i rådet. - Vi är hedrade att ha experter med specialistkompetens inom området immunonkologi och cellterapi i vårt vetenskapliga råd, vilka kan erbjuda ytterligare vägledning när det

Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board17.9.2018 08:00Pressmeddelande

Press Release 17 September 2018 Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board Immunicum AB (publ; IMMU.ST) announced today the appointment of leading oncology experts to its Scientific Advisory Board with the addition of Pawel Kalinski, MD, PhD, Vice Chair for Translational Research within the Department of Medicine at Roswell Park Comprehensive Cancer Center, and Inge Marie Svane, MD, PhD, Professor, Head of the Clinical Cancer Research programme, Faculty of Health Sciences, University of Copenhagen, Director, Centre for Cancer Immunotherapy (CCIT), and consultant in Oncology, Herlev University Hospital. Both Scientific Advisory Board members will serve as a strategic resource to Immunicum as the company continues to advance the clinical development of its lead product, ilixadencel. "We are honored to have such highly specialized experts in the field of immuno-oncology and cell therapy join our Scientific Advisory Board a

Hoylu AB: HOYLU HIRES NEW CTO, SATOSHI NAKAJIMA AND ANNOUNCES EXPANSION INTO JAPAN14.9.2018 08:30Pressmeddelande

Malmo, Sweden, September 14, 2018 - Hoylu, a leading enterprise collaboration company, announced today Satoshi Nakajima will join Hoylu in the newly created position, as Chief Technology Officer and President of Hoylu Japan. Nakajima will guide the strategic technology direction and innovation of Hoylu while also leading the new Hoylu office in Tokyo, Japan. "Satoshi is a visionary and world-class technologist who has substantial experience in delivering world class innovations. He is joining the Company as we are extending our reach and expanding into Japan," said Stein Revelsby, CEO. "Satoshi's extensive experience in strategy and delivering technology that support a great user experience will make an immediate impact on the company." Nakajima will serve as President of Hoylu Japan and will report to Stein Revelsby. His leadership will strengthen customer relations and help develop new business among emerging and established Japanese companies while strengthening the global position

Hoylu AB: HOYLU ANSTÄLLER SATOSHI NAKAJIMA SOM NY CTO OCH EXPANDERAR TILL JAPAN14.9.2018 08:30Pressmeddelande

Malmö, Sverige, 14 september 2018 - Hoylu, ett ledande företag inom samarbetsmjukvara för företagsmarknaden annonserar idag att Satoshi Nakajima tar anställning som CTO (Chief Technology Officer) och President för Hoylu Japan. Nakajima kommer styra den strategiska inriktningen för företagets produkter och leda innovationsarbetet. Han kommer också leda Hoylus nyöppnade kontor i Tokyo, Japan. Satoshi är en visionär teknologiexpert som har stor erfarenhet av att skapa innovativa lösningar. Han kommer till Hoylu samtidigt som vi utökar marknaden till att även täcka in Japan säger Stein Revelsby, VD. "Satoshis långa och gedigna erfarenhet i strategiska frågor och tekniska lösningar med fokus på användarupplevelse kommer få stor betydelse för oss." Nakajima kommer även att bli President för Hoylu Japan och kommer rapportera till Stein Revelsby. Hans ledarskap kommer stärka existerande kundrelationer och utveckla nya affärer på den japanska marknaden och samtidigt bidra till att flytta fram p

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum